Therapy-induced tumour secretomes promote resistance and tumour progression-Reference-Cited by-同舟云学术

Therapy-induced tumour secretomes promote resistance and tumour progression

Published:2015-03-25 Issue:7547 Volume:520 Page:368-372
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Obenauf Anna C.,Zou Yilong,Ji Andrew L.,Vanharanta Sakari,Shu Weiping,Shi Hubing,Kong Xiangju,Bosenberg Marcus C.,Wiesner Thomas,Rosen Neal,Lo Roger S.,Massagué Joan

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature14336.pdf

Reference38 articles.

1. Engelman, J. A. & Settleman, J. Acquired resistance to tyrosine kinase inhibitors during cancer therapy. Curr. Opin. Genet. Dev. 18, 73–79 (2008)

2. Holohan, C., Van Schaeybroeck, S., Longley, D. B. & Johnston, P. G. Cancer drug resistance: an evolving paradigm. Nature Rev. Cancer 13, 714–726 (2013)

3. Chapman, P. B. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med. 364, 2507–2516 (2011)

4. Sosman, J. A. et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N. Engl. J. Med. 366, 707–714 (2012)

5. Shaw, A. T. & Engelman, J. A. ALK in lung cancer: past, present, and future. J. Clin. Oncol. 31, 1105–1111 (2013)

Cited by 394 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolutionary theory of cancer: challenges and potential solutions;Nature Reviews Cancer;2024-09-10

2. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities;Nature Reviews Cancer;2024-09-02

3. Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act;Cancer Treatment Reviews;2024-09

4. Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy;Cell;2024-09

5. Timing of treatment shapes the path to androgen receptor signaling inhibitor resistance in prostate cancer;2024-07-01